| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $3.92 (Beat by $0.17) |
| EPS GAAP Actual | $3.92 (Beat by $0.17) |
| Revenue Actual | $6.1871B |
| Revenue Surprise | Beat by $6187.1M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $5.1798B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 18.6049 | 16.95 | 18.34704 | 18.87313 | 1 |
| Dec 2027 | 18.10381 | 17.41 | 17.03455 | 18.4267 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.79 | -1.058 | 6.1871B | 11.28% | 74.38M |
| FQ2 2025 (Jun 2025) | 3.82 | 3.82 | 5.8996B | 7.12% | 5899.6M |
| FQ1 2025 (Mar 2025) | 2.1 | 2.1 | 5.3437B | -0.12% | 5343.7M |
| FQ4 2024 (Dec 2024) | 3.03 | 3.03 | 5.4997B | 0.48% | 5499.7M |
| FQ3 2024 (Sep 2024) | 3.87 | 3.87 | 5.4894B | -2.82% | 5489.4M |
| FQ2 2024 (Jun 2024) | 4.34 | 4.34 | 5.4797B | -4.85% | 5479.7M |
| FQ1 2024 (Mar 2024) | 1.99 | 1.99 | 5.35B | -3.21% | 5350M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 5.4734B | -1.55% | 5473.4M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
5.1798B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.95 | -- | 4.8733 | 5.05996 | 7 |
| FQ3 2027 (Sep 2027) | 5.42 | -- | 5.35447 | 5.517 | 2 |
| FQ2 2027 (Jun 2027) | 4.9 | -- | 4.84076 | 4.98769 | 2 |
| FQ1 2027 (Mar 2027) | 3.78 | -- | 3.7343 | 3.84765 | 2 |
| FQ4 2026 (Oct 2026) | 4.89 | -- | 4.72426 | 5.1272 | 3 |
| FQ3 2026 (Jul 2026) | 5.16 | 26.55 | 4.98511 | 5.4103 | 4 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 4 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.15B | -- | 6.07B | 6.25B | 3 |
| FQ3 2027 (Sep 2027) | 6.27B | -- | 6.21B | 6.36B | 2 |
| FQ2 2027 (Jun 2027) | 6.06B | -- | 6B | 6.14B | 2 |
| FQ1 2027 (Mar 2027) | 5.8B | -- | 5.74B | 5.88B | 2 |
| FQ4 2026 (Oct 2026) | 6.01B | -- | 5.85B | 6.23B | 4 |
| FQ3 2026 (Jul 2026) | 5.85B | -5.82 | 5.69B | 6.07B | 5 |
| FQ2 2026 (Jun 2026) | 5.85B | -0.9 | 5.68B | 6.02B | 6 |
| FQ1 2026 (Mar 2026) | 5.18B | -3.16 | 5.03B | 5.33B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 4.848 | 3.79 | -1.058 | -27.92% |
| FQ2 2025 (Jun 2025) | 3.82 | 3.82 | 100% | |
| FQ1 2025 (Mar 2025) | 2.1 | 2.1 | 100% | |
| FQ4 2024 (Dec 2024) | 3.03 | 3.03 | 100% | |
| FQ3 2024 (Sep 2024) | 3.87 | 3.87 | 100% | |
| FQ2 2024 (Jun 2024) | 4.34 | 4.34 | 100% | |
| FQ1 2024 (Mar 2024) | 1.99 | 1.99 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $6.11B | $6.19B | $74.38M | 1.2% |
| FQ2 2025 (Jun 2025) | $0B | $5.9B | $5899.6M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $5.34B | $5343.7M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.5B | $5499.7M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $5.49B | $5489.4M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.48B | $5479.7M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.35B | $5350M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $5.47B | $5473.4M | 100% |